Young people with a rare condition called Juvenile Idiopathic Arthritis (JIA) are taking part in clinical research to better understand the condition, including to find out why some children have more ...

Patients with JIA-associated uveitis who discontinued adalimumab had higher recurrence rates than those who continued the ...

Declan LeBaron, an 8-year-old Philadelphia Eagles super fan, told Fox News Digital how he felt when he was surprised by ...

Juvenile idiopathic arthritis (JIA) is a chronic inflammatory condition that affects children and is characterized by arthritis lasting for more than six weeks with an onset before the age of 16.

Methotrexate (MTX) is the widely agreed upon first-choice second-line agent to treat juvenile idiopathic arthritis (JIA), up to 75% of JIA patients in recent registries have used MTX at some time ...

Autoimmune disorders in children can cause symptoms often mistaken for common childhood illnesses. More precise diagnoses and ...

The FDA's approval is grounded in an evidence totality and comprehensive data package, which includes outcomes from a study.

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, ...

The consensus based term for a rheumatic joint disorder in childhood is “juvenile idiopathic arthritis (JIA)”, and not “juvenile rheumatic coxitis.” [note: the author points out a mistake ...